Drug Price Regulation, B.C. Reg. 344/2012

Section 12

Price if unanticipated drug shortage

Cite as Drug Price Regulation, B.C. Reg. 344/2012, s. 12 · last amended March 1, 2026 · read from BC Laws on November 17, 2026

The text

(1) This section applies to (a) a brand drug within an LCA category having an insufficient supply of drugs as described in section 16 (1) [temporary listing of drugs], and (b) a drug that is temporarily listed under section 16 (2). (2) If section 16 (1) applies, despite sections 9 [maximum payment for non-reference drugs] to 11 [prices for other drugs], the maximum amount the minister may pay for a drug referred to in subsection (1) of this section during the period of unanticipated shortage is as follows: (a) if the drug is a non-reference drug, the lesser of (i) the sum of the manufacturer's list price for the drug and 8% of that price, and (ii) the maximum daily amount the minister may pay for the reference drug comparator for the reference drug category to which the non-reference drug belongs, as if the reference drug comparator were being dispensed at the daily therapeutic dose determined under section 6 (5) [reference drug program]; (b) if the drug is a high cost drug, the sum of the manufacturer's list price for the drug and 5% of that price; (c) in any other case, the sum of the manufacturer's list price for the drug and 8% of that price.
Read the Drug Price Regulation on BC Laws ↗

Made under Pharmaceutical Services Act, SBC 2012, c. 22.